INS and type 2 diabetes mellitus: In NAFLD mice, butyrate restores intestinal barrier function by increasing ZO-1 expression and mitigates metabolic disorders and intestinal epithelial impairment in type 2 diabetic mice by promoting insulin secretion without compensatory hyperplasia in pancreatic β cells [293].